As investors eagerly await the allotment status of the SBFC Finance Initial Public Offering (IPO), significant developments are on the horizon. The anticipated allotment...
As the Concord Biotech IPO approaches its conclusion, market enthusiasts are closely monitoring the grey market premium (GMP) and subscription status to gauge investor...
Chip designer Arm is redirecting its research efforts towards more commercially viable products and limiting its "blue sky" research. As part of a strategy...